tiprankstipranks
eXoZymes (EXOZ)
NASDAQ:EXOZ
US Market
EXOZ
eXoZymes
RESEARCH TOOLSreports
Want to see EXOZ full AI Analyst Report?

eXoZymes (EXOZ) Ratios

14 Followers

eXoZymes Ratios

EXOZ's free cash flow for Q4 2025 was $0.00. For the 2025 fiscal year, EXOZ's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Dec 23Dec 22
Liquidity Ratios
Current Ratio
 ― 2.51 8.12 0.50 2.32
Quick Ratio
 ― 2.51 8.12 0.50 2.32
Cash Ratio
 ― 1.94 7.29 0.03 0.88
Solvency Ratio
 ― -3.45 -2.14 -0.47 -0.95
Operating Cash Flow Ratio
 ― -4.15 -6.38 -0.49 -1.98
Short-Term Operating Cash Flow Coverage
 ― 0.00 0.00 0.00 0.00
Net Current Asset Value
$ ―$ 1.37M$ 8.21M$ -2.73M$ 156.11K
Leverage Ratios
Debt-to-Assets Ratio
 ― 0.21 0.11 0.45 0.23
Debt-to-Equity Ratio
 ― 0.37 0.13 -4.19 0.44
Debt-to-Capital Ratio
 ― 0.27 0.12 1.31 0.31
Long-Term Debt-to-Capital Ratio
 ― 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 ― 1.76 1.25 -9.26 1.96
Debt Service Coverage Ratio
 ― 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 ― 0.00 0.00 0.00 0.00
Debt to Market Cap
 ― 0.00 0.00 0.00 0.00
Interest Debt Per Share
 ― 0.15 0.17 0.20 0.07
Net Debt to EBITDA
 ― 0.19 1.49 -0.97 -0.04
Profitability Margins
Gross Profit Margin
―0.00%0.00%0.00%0.00%
EBIT Margin
―0.00%0.00%0.00%0.00%
EBITDA Margin
―0.00%0.00%0.00%0.00%
Operating Profit Margin
―0.00%0.00%0.00%0.00%
Pretax Profit Margin
―0.00%0.00%0.00%0.00%
Net Profit Margin
―0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
―0.00%0.00%0.00%0.00%
Net Income Per EBT
―98.86%100.00%102.12%104.77%
EBT Per EBIT
―95.34%98.81%111.13%99.99%
Return on Assets (ROA)
―-153.37%-44.97%-57.28%-51.98%
Return on Equity (ROE)
―-269.59%-56.25%530.39%-101.72%
Return on Capital Employed (ROCE)
―-220.60%-50.70%-157.12%-64.97%
Return on Invested Capital (ROIC)
―-203.05%-49.72%-131.28%-60.68%
Return on Tangible Assets
―-153.37%-44.97%-57.28%-51.98%
Earnings Yield
―-10.03%-4.37%-2.90%-1.99%
Efficiency Ratios
Receivables Turnover
 ― 0.00 0.00 0.00 0.00
Payables Turnover
 ― 0.00 0.29 0.00 0.38
Inventory Turnover
 ― 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 ― 0.00 0.00 0.00 0.00
Asset Turnover
 ― 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 ― 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 ― 0.00 -1.26K 0.00 -953.06
Days of Sales Outstanding
 ― 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 ― 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 ― 0.00 1.26K 0.00 953.06
Operating Cycle
 ― 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 ― -0.78 -1.05 -0.15 -0.15
Free Cash Flow Per Share
 ― -0.80 -1.10 -0.18 -0.18
CapEx Per Share
 ― 0.02 0.05 0.04 0.02
Free Cash Flow to Operating Cash Flow
 ― 1.03 1.05 1.24 1.15
Dividend Paid and CapEx Coverage Ratio
 ― -38.27 -21.45 -4.09 -6.76
Capital Expenditure Coverage Ratio
 ― -38.27 -21.45 -4.09 -6.76
Operating Cash Flow Coverage Ratio
 ― -5.23 -6.13 -0.73 -2.06
Operating Cash Flow to Sales Ratio
 ― 0.00 0.00 0.00 0.00
Free Cash Flow Yield
―-7.30%-6.64%-2.09%-2.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 ― -9.97 -22.88 -34.49 -50.35
Price-to-Sales (P/S) Ratio
 ― 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 ― 26.89 12.87 -182.93 51.22
Price-to-Free Cash Flow (P/FCF) Ratio
 ― -13.69 -15.06 -47.84 -48.72
Price-to-Operating Cash Flow Ratio
 ― -14.05 -15.77 -59.53 -55.92
Price-to-Earnings Growth (PEG) Ratio
 ― -0.19 -0.12 -0.73 -3.78
Price-to-Fair Value
 ― 26.89 12.87 -182.93 51.22
Enterprise Value Multiple
 ― -9.50 -22.48 -44.92 -59.38
Enterprise Value
 ― 89.56M 125.77M 71.85M 70.35M
EV to EBITDA
 ― -9.50 -22.48 -44.92 -59.38
EV to Sales
 ― 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 ― -13.42 -14.13 -48.89 -48.75
EV to Operating Cash Flow
 ― -13.77 -14.79 -60.84 -55.96
Tangible Book Value Per Share
 ― 0.41 1.28 -0.05 0.17
Shareholders’ Equity Per Share
 ― 0.41 1.28 -0.05 0.17
Tax and Other Ratios
Effective Tax Rate
 ― 0.01 0.00 -0.02 -0.05
Revenue Per Share
 ― 0.00 0.00 0.00 0.00
Net Income Per Share
 ― -1.09 -0.72 -0.25 -0.17
Tax Burden
 ― 0.99 1.00 1.02 1.05
Interest Burden
 ― 0.95 1.00 1.11 1.00
Research & Development to Revenue
 ― 0.00 0.00 0.00 0.00
SG&A to Revenue
 ― 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 ― 0.00 0.00 0.00 0.00
Income Quality
 ― 0.71 1.45 0.58 0.90
Currency in USD